SMS Pharmaceuticals Ltd Files BRSR for FY 2025-26

SMS Pharmaceuticals Ltd has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report, which is part of the Annual Report, details the company's corporate identity, business activities, operations, and employee data. Key disclosures include the company's CIN, registered office, contact details, and stock exchange listings on BSE and NSE. The company's primary business activity is the manufacture of Active Pharmaceutical Ingredients (APIs), accounting for 99.21% of its turnover. Exports contribute 66% of the total turnover, serving a diverse range of pharmaceutical companies worldwide. The report also provides employee statistics, including permanent and non-permanent staff, and details on gender representation. The BRSR is prepared on a standalone basis.